BioPharma Credit PLC
BOPCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,081 | $1,100 | $1,305 | $1,330 |
| - Cash | $6 | $86 | $121 | $95 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1,075 | $1,014 | $1,185 | $1,235 |
| Revenue | $124 | $160 | $214 | $126 |
| % Growth | -22.1% | -25.3% | 69.1% | – |
| Gross Profit | $124 | $110 | $184 | $88 |
| % Margin | 100% | 69.2% | 86.2% | 69.6% |
| EBITDA | $122 | $0 | $0 | $0 |
| % Margin | 98.2% | 0% | 0% | 0% |
| Net Income | $122 | $108 | $182 | $85 |
| % Margin | 98.2% | 67.9% | 85.3% | 67.2% |
| EPS Diluted | 0.1 | 0.083 | 0.13 | 0.062 |
| % Growth | 20.8% | -36.3% | 110.4% | – |
| Operating Cash Flow | $112 | $123 | $184 | $96 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $112 | $123 | $184 | $96 |